Resident characteristics and organizational factors influencing the quality of drug use in Swedish nursing homes

Social Science and Medicine

Volumn 47, Issue 7, 1998, Pages 961-971

  Schmidt, Ingrid ^a,d   Claesson, Cecilia B ^b   Westerholm, Barbro ^c   Svarstad, Bonnie L ^d  

^a Apoteket AB   (Sweden)

^b NATIONAL BOARD OF HEALTH AND WELFARE   (Sweden)

^c Network for Pharmacoepidemiology Foundation   (Sweden)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Drug utilization; Nursing homes; Psychotropics; Quality criteria; Quality of care

Indexed keywords

PSYCHOTROPIC AGENT;

AGED; ARTICLE; DRUG USE; FEMALE; GERONTOPSYCHIATRY; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NURSING; NURSING HOME; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; STAFF; SWEDEN;

AGED; AGED, 80 AND OVER; DRUG UTILIZATION; FEMALE; HUMANS; MALE; NURSING HOMES; PHYSICIAN'S PRACTICE PATTERNS; PSYCHOTROPIC DRUGS; QUALITY OF HEALTH CARE; SWEDEN;

EID: 0031855271     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0277-9536(98)00169-5     Document Type: Article

References (35)

1. Andersson, M. (1989) Drugs prescribed for patients in nursing homes or under medical care. Compre. Gerontol. Suppl., A + B, 8-15.
2. Avorn, J., Soumerai, S. B., Everitt, D. E., Ross-Degan, D., Beers, M. H., Sherman, D., Salem-Schatz, S. R. and Fields, D. (1992) A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N. Engl. J. Med. 327, 168-173.
3. Avorn, J. and Gurwitz, J. H. (1995) Drug use in the nursing home. Ann. Int. Med. 123, 195-204.
4. Becker, M. H. et al. (1972) Differential education concerning therapeutics and result on physician prescribing patterns. J. Med. Edu. 47, 119-127.
5. Beers, M. H., Avorn, J., Soumerai, S. B., Everitt, D. E., Sherman, D. S. and Salem, S. (1988) Psychoactive medication use in intermediates care facility residents. JAMA 260, 3016-3020.
6. Beers, M. H., Fingold, S. F., Ouslander, J. G., Reuben, D. B., Morgenstern, H. and Beck, J. C. (1993) Characteristics and quality of prescribing by doctors practicing in nursing homes. J. Am. Geriatric Soc. 41, 801-807.
7. Buck, J. F. (1988) Psychotropic drug practice in nursing homes. J. Am. Geriatric Soc. 36, 409-418.
8. Burns, B. J. and Kamerow, D. B. (1988) Psychotropic prescription for nursing home residents. J. Fam. Pract. 26, 155-160.
9. Garrard, J., Makris, L., Dunham, T., Heston, L., Cooper, S., Ratner, E., Zelterman, D. and Kane, R. (1991) Evaluation of neuroleptic drug use by nursing home elderly under proposed medicare and medicaid regulations. JAMA 265, 463-467.
10. Garrard, L. (1995) The impact of the 1987 federal regulations on the use of drugs in Minnesota nursing homes. Am. J. Public Health 85, 771-776.
11. Glasspoole, L. A. and Aman, M. G. (1988) Attitudes and knowledge of gerontological nurses toward psychotropic drugs. Gerontologist 28, 667-671.
12. Guidelines for ATC Classification. WHO Collaborating Center for Drug Statistics Methodology, Norway and Nordic Council on Medicines, Sweden, 1993 and 1994.
13. Gulmann, N. C. (1993) Demens og etik: Fra psykofarmaka til livstestamente. Nord. Med. 108, 266-269.
14. Harrington, C., Tompkins, C., Curtis, M. and Grant, L. (1992) Psychotropic drug use in long-term care facilities: a review of the literature. Gerontologist 32, 822-833.
15. Lindley, M., Tully, M. P., Paramsothy, V. and Tallis, R. C. (1992) Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Aging 21, 294-300.
16. Lipton, H. L., Bero, L. A., Bird, J. A. and McPhee, S. J. (1992) The impact of clinical pharmacistś consultations on physicians geriatric drug prescribing. Med. Care 30, 646-654.
17. McGrath, A. M. and Jackson, G. A. (1996) Survey of neuroleptic prescribing in residents of nursing homes in Glasgow. BMJ 312, 611-612.
18. Medical Products Agency and The Norwegian Medicines Control Authority (1995). Treatment of mental conditions in patients with dementia. Workshop, 1.
19. Mort, J. R., Singh, Y. N., Gaspar, P. M., Adams, P. L. and Singh, N. N. (1993) Attitudes and knowledge of long term care nurses towards psychotropic medication for the elderly. Clin. Gerontol. 13, 13-31.
20. Mount, J. (1992) Nursing home responsiveness to research requests: results of a field study. Gerontologist 32, 414-419.
21. Mount, J. K. and Svarstad, B. L. (1991) Using the Wisconsin psychotropic screening protocol to assess the quality of nursing home residents psychotropic drug orders. Paper presented at 4th Conference Susted 91, June 10, 1991, Barcelona.
22. National Board of health and welfare: drug use in nursing homes. Special Report 1996, Stockholm.
23. Ray, W. A., Federspiel, C. F. and Schaffner, W. (1980) A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse. Am. J. Public Health 70, 485-491.
24. Rovner, B. W., Edelman, B. A., Cox, M. P. and Shmuely, Y. (1992) The impact of antipsychotic drug regulations on psychotropic drug prescribing practices in nursing homes. Am. J. Psychiat. 149, 1390-1392.
25. Schmader, K., Hanlon, J. T., Weinberger, M., Landsman, P. B., Samsa, G. P., Lewis, I., Uttech, K., Cohen, J. H. and Feussner, J. R. (1994) Appropriateness of medication prescribing in ambulatory elderly patients. J. Am. Geriatr. Soc. 42, 1241-1247.
26. Schmidt, I. K., Claesson, C. B., Westerholm, B., Nilsson, L. G. and Svarstad, B. L. (1998) The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J. Am. Geriatr. Soc. 46, 77-82.
27. Schwartz, R. K., Soumerai, S. B. and Avorn, J. (1989) Physician motivations for nonscientific drug prescribing. Soc. Sci. Med. 28, 577-582.
28. Shorr, R. I., Fought, R. L. and Ray, W. A. (1994) Changes in antipsychotic drug use in nursing home during implementation of the OBRA-87 regulation. JAMA 271, 358-363.
29. Shortell, S. M., O'Brian, J. L., Carman, J. M., Foster, R. W., Hughes, E. F. X., Boerstler, H. and O'Connor, E. J. (1995) Assessing the impact of continuous quality improvement/total quality management: concept versus implementation. Health Serv. Res. 30, 377-401.
30. Snowdon, J., Vaugan, R., Miller, R., Burgess, E.E. and Tremlett, P. (1995) Psychotropic drug use in Sydney nursing homes. Med. J. Aust. 163(2), 70-72.
31. Starr, M. and Whalley, L. J. (1994) Drug induced dementia. Drug Safety 11, 310-317.
32. Svarstad, B. L. and Mount, J. K. (1991) Nursing home resources and tranquilizer use among the institutionalized elderly. J. Am. Geriatr. Soc. 39, 869-875.
33. Svarstad, B. L. (1992). Sleep medication use in skilled nursing facilities: Effects of nurse beliefs and norms. Wisconsin Mental Health Research Center Research Paper Series No. 21.
34. Zimmerman, D. R., Karon, S. L., Arling, G., Clark, B. R., Collins, T., Ross, R. and Sainfort, F. (1995) Development and testing of nursing home quality indicators. Health Care Financing Review 16, 107-128.
35. Zinn, J. S., Aaronsson, W. E. and Rosko, M. D. (1993) Variations in the outcomes of care provided in Pennsylvania nursing homes. Med. Care 31, 47-487.